St. Vincentius - Kliniken
Karlsruhe, Germany
Surgical center in Karlsruhe, Baden-Württemberg
Südendstraße 32, 76137 Karlsruhe
About St. Vincentius - Kliniken
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
AGO Study Group
5
AGO Research GmbH
4
German CLL Study Group
2
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2
University of Jena
2
Universität des Saarlandes
2
AIO-Studien-gGmbH
1
Aktion Bronchialkarzinom e.V.
1
Alliance Foundation Trials, LLC.
1
Clinical Trials at St. Vincentius - Kliniken
During the past decade, St. Vincentius - Kliniken conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 11 clinical trials were completed, i.e. on
average, 47.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
1999-12-01
2006-08-01
Completed
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
2001-08-01
Completed
105
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
2001-08-01
Completed
63
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
2002-08-01
2011-01-01
Completed
1,742
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St. Vincentius - Kliniken" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "AGO Study Group" with 5 trials
sponsored, "AGO Research GmbH" with 4 trials sponsored, "German CLL Study Group" with 2 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group"
with 2 trials sponsored. Other sponsors include 27 different institutions and
companies that sponsored additional 34 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincentius - Kliniken"
#1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator, "German Breast Group" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator and "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were
collaborators in the rest 64 trials.
Clinical Trials Conditions at St. Vincentius - Kliniken
According to Clinical.Site data, the most researched conditions in "St. Vincentius - Kliniken" are
"Ovarian Cancer" (9 trials), "Breast Cancer" (7 trials), "Fallopian Tube Cancer" (7 trials), "Leukemia" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "St. Vincentius - Kliniken" in a lesser frequency.
Clinical Trials Intervention Types at St. Vincentius - Kliniken
Most popular intervention types in "St. Vincentius - Kliniken" are "Drug" (54 trials), "Biological" (6 trials), "Radiation" (5 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (9 trials), "Bevacizumab" (7 trials), "Gemcitabine" (6 trials), "Paclitaxel" (5 trials) and "Placebo" (5 trials). Other intervention names were less common.
Clinical Trials Genders at St. Vincentius - Kliniken
The vast majority of trials in "St. Vincentius - Kliniken" are
32 trials for "All" genders and 24 trials for "Female" genders.
Clinical Trials Status at St. Vincentius - Kliniken
Currently, there are NaN active trials in "St. Vincentius - Kliniken".
undefined are not yet recruiting,
9 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in St. Vincentius - Kliniken,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in St. Vincentius - Kliniken, 1 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 42 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of St. Vincentius - Kliniken
St. Vincentius - Kliniken has several departments that took part in Clinical trials: "St. Vincentius Kliniken Karlsruhe; Abteilung Hämatologie / Onkologie" - 3 trials
Departments List
Name
City
Trials